KIRA OGOSHI: Open Payments
NPI 1831836527 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $256 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $116 |
| Optinose US, Inc. | 2 | $44 |
| AERIN MEDICAL INC. | 1 | $36 |
| GENZYME CORPORATION | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Amgen Inc. | 1 | $17 |
Products named: Xhance, VIVAER STYLUS, DUPIXENT, NUCALA, TEZSPIRE.
Industry payments across MD — which companies pay providers there.
